The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
MicroRNAs in cancer: biomarkers, functions and therapy
Open accessAbstract
The emergence of microRNAs has been one of the defining developments in cancer biology over the past decade, and the explosion of knowledge in this area has brought forward new diagnostic and therapeutic opportunities. The importance of microRNAs in cancer has been underlined by the identification of alterations in microRNA target binding sites and the microRNA processing machinery in tumor cells. Clinical trials utilizing microRNA profiling for patient prognosis and clinical response are now underway, and the first microRNA mimic entered the clinic for cancer therapy in 2013. In this article we review the potential applications of microRNAs for the clinical assessment of patient outcome in cancer, as well as in cancer monitoring and therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
1 retracted
HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
Kumar, M. S., Armenteros-Monterroso, E., East, P., Chakravorty, P., Matthews, N., Winslow, M. M., & Downward, J. (2013) · Nature · doi:10.1038/nature12785 · Cited by 255
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
miRBase: tools for microRNA genomics
Griffiths‐Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,432
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,262
Research works printed but not linked: 1
- Choudhury, 2012, Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells, J. Clin. Invest., 122, 4059, 10.1172/JCI62925 · DOI
Cited by
Sorted by citations
Items 801–900 of 1,000
Fan, T., Mao, Y., Liu, F., Zhang, W., Lin, J., Yin, J., Tan, Y. C., Huang, X., & Jiang, Y. (2019) · Talanta · doi:10.1016/j.talanta.2019.01.038 · Cited by 26
Guo, H., Zhang, X., Chen, Q., Bao, Y., Dong, C., & Wang, X. (2018) · PubMed Central · Cited by 26
MicroRNAs: pivotal regulators in acute myeloid leukemia
Li, M., Cui, X., & Guan, H. (2020) · Annals of Hematology · doi:10.1007/s00277-019-03887-5 · Cited by 26
Chen, G., Gu, H., Fang, T., Zhou, K., Xu, J., & Yin, X. (2020) · Aging · doi:10.18632/aging.103049 · Cited by 26
Niu, Y., Tong, J., Shi, X., & Zhang, T. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8878 · Cited by 26
Baba, S., Kawasaki, T., Hirano, S., Nakamura, T., Asano, T., Okazaki, R., Yoshida, K., Kawase, T., Kurahara, H., Oi, H., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102936 · Cited by 26
Kleemann, M., Bereuther, J., Fischer, S., Marquart, K. F., Hänle, S., Unger, K., Jendrossek, V., Riedel, C. U., Handrick, R., & Otte, K. (2016) · Oncotarget · doi:10.18632/oncotarget.13095 · Cited by 25
Fang, L., Kong, D., & Xu, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.043 · Cited by 25
Peng, Q.-P., Du, D., Ming, Q., Hu, F., Wu, Z.-B., & Qiu, S. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2017.64.15.10 · Cited by 25
Fan, B., Shen, C., Wu, M., Zhao, J., Guo, Q., & Luo, Y. (2018) · Medicine · doi:10.1097/md.0000000000012007 · Cited by 25
miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1
Gong, X., Xu, B., Li, Z., & Chen, X. (2019) · Cancer Management and Research · doi:10.2147/cmar.s208708 · Cited by 25
Bao, M.-R., Liu, G., Song, J. L., & Gao, Y. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03246-1 · Cited by 25
miR-197-3p reduces epithelial–mesenchymal transition by targeting ABCA7 in ovarian cancer cells
Xie, W., Shui, C., Fang, X., Peng, Y., & Li, Q. (2020) · 3 Biotech · doi:10.1007/s13205-020-02362-7 · Cited by 25
The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer
Liu, S.-S., Li, Y., Zhang, H., Zhang, D., Zhang, X.-B., Wang, X., & Yu, Y. (2020) · Theranostics · doi:10.7150/thno.46297 · Cited by 25
Zhang, H., Kang, J., Liu, L., Chen, L., Ren, S., & Tao, Y. (2020) · Aging · doi:10.18632/aging.103614 · Cited by 25
Oncogenic and tumor suppressor function of MEIS and associated factors
Girgin, B., Alpaslan, M. K., & Kocabaş, F. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2006-25 · Cited by 25
Proline dehydrogenase in cancer: apoptosis, autophagy, nutrient dependency and cancer therapy
Liu, Y., Mao, C., Liu, S., Xiao, D., Shi, Y., & Tao, Y. (2021) · Amino Acids · doi:10.1007/s00726-021-03032-5 · Cited by 25
Advanced graphene oxide-based paper sensor for colorimetric detection of miRNA
Lee, J., Na, H., Lee, S., & Kim, W. (2021) · Microchimica Acta · doi:10.1007/s00604-021-05140-1 · Cited by 25
Wang, L., Yang, L., Zhuang, T., & Shi, X. (2022) · Journal of Immunology Research · doi:10.1155/2022/4769385 · Cited by 25
Huang, D., Shen, P., Xu, C., Xu, Z., Cheng, D., Zhu, X., Fang, M., Wang, Z., & Xu, Z. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114957 · Cited by 25
García‐Giménez, J. L., Ushijima, T., & Tollefsbol, T. O. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801899-6.00001-2 · Cited by 25
miR-125b regulates cell progression in chronic myeloid leukemia via targeting BAK1.
Li, Q., Wu, Y., Zhang, Y., Sun, H., Lu, Z., Du, K., Fang, S., & Li, W. (2016) · PubMed Central · Cited by 25
ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition
Stacy, A. J., Craig, M. P., Sakaram, S., & Kadakia, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13797 · Cited by 26
Davari, M., Soheili, Z., Samiei, S., Sharifi, Z., & Pirmardan, E. R. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.071 · Cited by 25
Implications of MicroRNAs in Oncolytic Virotherapy
Ros, X. B., Rovira-Rigau, M., & Fillat, C. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00142 · Cited by 27
MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers
Cheng, W.-T., Rosario, R., Muthukaruppan, A., Wilson, M. K., Payne, K., Fong, P. C. C., Shelling, A. N., & Blenkiron, C. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0372-0 · Cited by 25
Zhuge, B., & Li, G. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.149 · Cited by 25
YU, F. Y., Zhou, C., LIU, Y. B., WANG, B., MAO, L., & LI, Y. (2018) · Neoplasma · doi:10.4149/neo_2018_170608n411 · Cited by 25
Zheng, H., Ramnaraign, D., Anderson, B. A., Tycksen, E., Nunley, R. M., & McAlinden, A. (2018) · JBMR Plus · doi:10.1002/jbm4.10071 · Cited by 26
miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
Kordaß, T., Weber, C. E. M., Eisel, D., Pane, A. A., Osen, W., & Eichmüller, S. B. (2018) · Oncotarget · doi:10.18632/oncotarget.25986 · Cited by 25
Zheng, X., Xu, C., & Wang, F. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2018.64.11.6 · Cited by 25
A microRNA signature for the differential diagnosis of salivary gland tumors
Denaro, M., Navari, E., Ugolini, C., Seccia, V., Donati, V. L., Casani, A. P., & Basolo, F. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210968 · Cited by 25
Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms
Rezapour, S., Hosseinzadeh, E., Marofi, F., & Hassanzadeh, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28658 · Cited by 25
Meijer, L. L., Puik, J. R., Large, T. Y. S. L., Heger, M., Dijk, F., Funel, N., Würdinger, T., Garajová, I., van Grieken, N. C. T., van de Wiel, M. A., et al. (2019) · Cancers · doi:10.3390/cancers11081181 · Cited by 25
Liang, K., Wang, H., Li, P., Zhu, Y., Liu, J., & Tang, B. (2019) · Talanta · doi:10.1016/j.talanta.2019.120285 · Cited by 25
The potential of engineered eukaryotic RNA‐binding proteins as molecular tools and therapeutics
Shotwell, C. R., Cleary, J. D., & Berglund, J. A. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1573 · Cited by 25
Zhang, D., Sun, G., Peng, L., Tian, J., & Zhang, H. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108478 · Cited by 25
Zhang, Q., Yin, X., & Zhang, Y. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.10.017 · Cited by 25
Gruszka, R., Zakrzewski, K. M., Liberski, P. P., & Zakrzewska, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020543 · Cited by 25
Ouyang, L., Liu, R.-D., Lei, D.-Q., Shang, Q.-C., Li, H., Hu, X., Zheng, H., & Jin, G. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-6556 · Cited by 25
miR-100 inhibits the migration and invasion of nasopharyngeal carcinoma by targeting IGF1R
Sun, X., Liu, X., Wang, Y., Yang, S., Chen, Y., & Yuan, T. (2018) · Oncology Letters · doi:10.3892/ol.2018.8420 · Cited by 24
Wen, Z., Chen, Y., Yu, L., Yu, J., & Li, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.005 · Cited by 25
Zhang, R., Shi, H., Ren, F., Liu, Z., Ji, P., Zhang, W., & Wang, W. (2019) · Journal of Cancer · doi:10.7150/jca.29502 · Cited by 24
Prognostic value of the tumor‐specific ceRNA network in epithelial ovarian cancer
Li, G., Han, L., Ren, F., Zhang, R., & Qin, G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28770 · Cited by 24
Jiang, Y., Tingran, W., Li, W., Zhang, R., & Chen, M. (2019) · Europe PMC (PubMed Central) · Cited by 24
Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma
Soliman, A. M., Teoh, S. L., Mahakkanukrauh, P., & Das, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207539 · Cited by 24
CircARL8B Contributes to the Development of Breast Cancer Via Regulating miR-653-5p/HMGA2 Axis
Wu, H., Xu, J., Gong, G., Zhang, Y., & Wu, S. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10082-7 · Cited by 24
Wong, C. L., Loke, S. Y., Lim, H. Q., Balasundaram, G., Chan, P. M. Y., Chong, B. K., Tan, E. Y., Lee, A. S. G., & Olivo, M. (2021) · Journal of Biophotonics · doi:10.1002/jbio.202100153 · Cited by 24
Wang, J., & Wu, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.1964895 · Cited by 24
Zhou, L., Wang, H., Fang, Z., Zhong, M., He, Y., Zou, J., Huang, S., Li, J., Xiang, X., & Fang, Z. (2021) · Bioengineered · doi:10.1080/21655979.2021.2003663 · Cited by 24
Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC
Oitabén, A., Fonseca, P., Villanueva, M. J., García-Benito, C., López‐López, A., Fernández, A. G., González-Ojea, C., Juaneda‐Magdalena, L., Lázaro, M. E., & Martínez‐Fernández, M. (2022) · Cancers · doi:10.3390/cancers14112626 · Cited by 26
Identifying the critical states and dynamic network biomarkers of cancers based on network entropy
Liu, J., Ding, D., Zhong, J., & Liu, R. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03445-0 · Cited by 24
Smith, L., Baxter, E. W., Chambers, P. A., Green, C. A., Hanby, A. M., Hughes, T. A., Nash, C. E., Millican-Slater, R. A., Stead, L. F., Verghese, E. T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139698 · Cited by 24
A novel miR-200b-3p/p38IP pair regulates monocyte/macrophage differentiation
Yu, X. H., Wang, Q., Li, Y., Wang, X., Xu, A., & Li, Y. (2016) · Cell Discovery · doi:10.1038/celldisc.2015.43 · Cited by 24
Switchable Protecting Strategy for Solid Phase Synthesis of DNA and RNA Interacting Nucleopeptides
Mercurio, M. E., Tomassi, S., Gaglione, M., Russo, R., Chambery, A., Lama, S., Stiuso, P., Cosconati, S., Novellino, E., Maro, S. D., et al. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b01829 · Cited by 24
A survey of software tools for microRNA discovery and characterization using RNA-seq
Bortolomeazzi, M., Gaffo, E., & Bortoluzzi, S. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx148 · Cited by 25
Functions and epigenetic aspects of miR-15/16: Possible future cancer therapeutics
Ramaiah, M. J. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.06.012 · Cited by 24
Photochemical Ligation to Ultrasensitive DNA Detection with Upconverting Nanoparticles
Méndez-González, D., Lahtinen, S., Laurenti, M., López‐Cabarcos, E., Rubio‐Retama, J., & Soukka, T. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03106 · Cited by 24
Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma
Milán-Rois, P., Latorre, A., Rodríguez-Díaz, C., del Moral, Á., & Somoza, Á. (2018) · Biomimetics · doi:10.3390/biomimetics3040028 · Cited by 24
Liu, B., Yu, Z.-H., Chen, A.-X., Chi, J.-R., Ge, J., Yu, Y., & Cao, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1112-4 · Cited by 24
miR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma
Li, J., Liu, X., Wang, W., & Li, C. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.86901 · Cited by 24
Zou, X., Li, M., Huang, Z., Xin Min, Z. H. O. U., Liu, Q., Xia, T., & Zhu, W. (2019) · Gene · doi:10.1016/j.gene.2019.144104 · Cited by 24
Huang, W., Huang, Y., Gu, J., Zhang, J., Yang, J., Liu, S., Xie, C., Fan, Y., & Wang, H. (2019) · PubMed Central · Cited by 24
LI, L. M., LUO, F. J., & SONG, X. (2020) · Neoplasma · doi:10.4149/neo_2020_190612n506 · Cited by 24
MicroRNA-144-3p Inhibits Tumorigenesis of Oral Squamous Cell Carcinoma by downregulating ERO1L
Li, X., Li, Y., Jiang, C., Chen, L., & Gan, N. (2019) · Journal of Cancer · doi:10.7150/jca.33267 · Cited by 24
MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma
Li, J., Jiang, D., Zhang, Q., Peng, S., Liao, G., Yang, X., Tang, J., Xiong, H., & Pang, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s253533 · Cited by 24
Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
Cheng, S., Zhang, Z., Hu, C., Xing, N., Xia, Y., & Pang, B. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s257329 · Cited by 24
Pourteimoor, V., Paryan, M., & Mohammadi‐Yeganeh, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26399 · Cited by 24
MicroRNA-539 inhibits glioma cell proliferation and invasion by targeting DIXDC1
Quan, J., Qu, J., & Zhou, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.097 · Cited by 23
Mir-23A Acts as An Oncogene in Pancreatic Carcinoma by Targeting Foxp2
Diao, H., Zhou, Y., & Qin, R. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000598 · Cited by 23
Role and mechanism of miR-4778-3p and its targets NR2C2 and Med19 in cervical cancer radioresistance
Zhang, Y., Li, P., Hu, J. R., Zhao, L., Li, J. P., Ma, R., Li, W. W., Shi, M., & Wei, L. C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.110 · Cited by 23
Liang, W., & Sun, F. (2019) · PeerJ · doi:10.7717/peerj.7441 · Cited by 23
The microRNA‑708‑5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma
Feng, T., Zhu, Z., Jin, Y., Wang, H., Mao, X., Liu, D., Li, Y., Lu, L., & Zuo, G. (2019) · Oncology Reports · doi:10.3892/or.2019.7452 · Cited by 23
Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
Ma, R., Zhao, Y., He, M., Zhao, H., Zhang, Y., Zhou, S., Gao, M., Di, D., Wang, J., Ding, J., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1074-9 · Cited by 23
Potential of microRNA based diagnostics and therapeutics in glioma: a patent review
Mondal, I., & Kulshreshtha, R. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1837775 · Cited by 23
Jia, Y., Shen, M., Zhou, Y., & Liu, H. (2020) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5225 · Cited by 23
Stable duplex-linked antisense targeting miR-148a inhibits breast cancer cell proliferation
Okumura, S., Hirano, Y., & Komatsu, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-90972-3 · Cited by 23
Wu, S., Zhou, P., Jian-xian, C., Lei, J., Li, H., Dong, Y., Hu, M., Lian, C., Yang, L., & Zhou, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01985-x · Cited by 23
Tian, S., Wang, J., Zhang, F., & Wang, D. (2022) · Genes · doi:10.3390/genes13030481 · Cited by 23
Ma, Z., Ma, Y., Xia, Q., Li, Y., Li, R., Chang, W., Chen, J., Leng, Z., & Tao, K. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2139-y · Cited by 23
MicroRNA-377 Downregulates Bcl-xL and Increases Apoptosis in Hepatocellular Carcinoma Cells
Ge, H., Zou, D., Wang, Y., Jiang, H., & Wang, L. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14719078133168 · Cited by 23
microRNA-664 enhances proliferation, migration and invasion of lung cancer cells
Zhu, X., Ju, S., Yuan, F., Chen, G., Shu, Y. L., Li, C., Xu, Y., Luo, J., & Xia, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4433 · Cited by 23
Circulating MicroRNA as Thrombosis Sentinels: Caveats and Considerations
Tay, J. W., Tiao, J. Y.-H., Hughes, Q., Jorritsma, J., Gilmore, G., & Baker, R. I. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1606568 · Cited by 23
Wang, Y., Zhang, H., Ge, S., Fan, Q., Zhou, L., Li, H., Bai, M., Ning, T., Liu, R., Wang, X., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6389 · Cited by 23
RetractedBabaei, E., Feizi, M. A. H., Soleimanpour, E., & Montazeri, V. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1227_16 · Cited by 23
Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells
Larcher, L. M., Wang, T., & Veedu, R. N. (2019) · Molecules · doi:10.3390/molecules24132489 · Cited by 23
Pan, Y., Zhu, X., Wang, K., & Chen, Y. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz066 · Cited by 23
Xu, D., Dong, P., Xiong, Y., Yue, J., Ihira, K., Konno, Y., Kobayashi, N., Todo, Y., & Watari, H. (2019) · Cancers · doi:10.3390/cancers11081130 · Cited by 23
Lu, X., Xue, B., Zhang, T., & Zhou, Y. Z. X. (2019) · General Physiology and Biophysics · doi:10.4149/gpb_2019041 · Cited by 23
Molecular prediction of metastasis in cutaneous squamous cell carcinoma
Mulvaney, P. M., & Schmults, C. D. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000609 · Cited by 25
Non-coding RNAs: ever-expanding diversity of types and functions
Lakhotia, S. C., Mallick, B., & Roy, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817193-6.00002-9 · Cited by 25
Li, Z., Li, Y., Wang, X., Liang, Y., Luo, D., Han, D., Li, C., Chen, T., Zhang, H., Liu, Y., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657094 · Cited by 23
Safe, S. H. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-014-0012-8 · Cited by 22
MicroRNA-643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma
Wang, H., Xing, D., Ren, D., Wei, F., Chen, Y., Zhao, Z., Xiao, Z., & Peng, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7273 · Cited by 22
RetractedCircRBMS3 promotes gastric cancer tumorigenesis by regulating miR‐153–SNAI1 axis
Li, G., Xue, M., Yang, F., Jin, Y., Fan, Y., & Li, W. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27122 · Cited by 22
Xi, K., Wang, W., Wen, Y., Chen, Y., Zhang, X., Wu, Y., Zhang, R., Wang, G., Huang, Z., & Zhang, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00975 · Cited by 22
Jiang, Z., Zhang, J., Chen, F., & Sun, Y. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13285 · Cited by 22
Lv, P., Luo, Y., Zhou, W., Liu, B., Zhou, Z., Shi, Y., Huang, R., Peng, C., He, Z., Wang, J., et al. (2020) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12191 · Cited by 23
Investigation of miRNA and mRNA Co-expression Network in Ependymoma
Liu, F., Dong, H. Y., Mei, Z., & Huang, T. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00177 · Cited by 22
Martínez‐Hernández, R., de la Fuente, H., Lamana, A., Sampedro-Nuñez, M. A., Ramos-Levi, A. M., Serrano-Somavilla, A., García‐Vicuña, R., Ortiz, A. M., Daudén, E., Llamas‐Velasco, M., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102472 · Cited by 22
Metadata
- Authors
- Hayes, J., Peruzzi, P. P., & Lawler, S.
- Affiliations
- St James's University Hospital (GB)
- The Ohio State University Wexner Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Lawler, Sean
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 20
- Issue
- 8
- Pages
- 460-469
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1974254202
- Cited by
- 2,049
- References
- 79
- Citations by year
- 2026: 61 · 2025: 78 · 2024: 103 · 2023: 130 · 2022: 186 · 2021: 244 · 2020: 290 · 2019: 273 · 2018: 235 · 2017: 203 · 2016: 140 · 2015: 91 · 2014: 12
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- microRNA, cancer, biomarkers, microRNA processing, miRNA expression profiling, prognosis, cancer therapy, miRNA mimics, cancer monitoring
- MeSH terms
- Animals, Humans, Neoplasms, Prognosis, Biomarkers, Tumor, Genetic Therapy, Gene Expression Regulation, Neoplastic, MicroRNAs, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review